Ritlecitinib
Ritlecitinib (pronounced rit-le-si-ti-nib) is a Janus kinase inhibitor used in the treatment of alopecia areata, a condition that causes hair loss.
Etymology
The name "Ritlecitinib" is derived from the class of drugs it belongs to, known as Janus kinase inhibitors. The suffix "-tinib" is commonly used for these types of drugs.
Pharmacology
Ritlecitinib works by inhibiting the Janus kinase (JAK) family of enzymes, which play a crucial role in the process of inflammation and immune response. By blocking these enzymes, Ritlecitinib can help to reduce inflammation and halt the progression of conditions like alopecia areata.
Usage
Ritlecitinib is primarily used in the treatment of alopecia areata, a condition that causes hair to fall out in small patches. The drug has shown promise in clinical trials, with many patients experiencing significant hair regrowth after treatment.
Side Effects
As with all medications, Ritlecitinib can cause side effects. The most common side effects include nausea, headache, and fatigue. More serious side effects can include changes in blood cell counts, liver problems, and increased risk of infection due to a weakened immune system.
Related Terms
External links
- Medical encyclopedia article on Ritlecitinib
- Wikipedia's article - Ritlecitinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski